Tenet Healthcare Corporation (NYSE:THC) Stock Has Average Target Price of $280.16 According to Brokerages

Key Points

• Analysts remain bullish on Tenet Healthcare: Twenty-one firms give the stock a consensus “Moderate Buy” rating, with an average 12-month price target of $280.16.
• Third-quarter results exceeded expectations: Tenet reported $6.64 in EPS versus the $4.68 consensus and revenue of $6.28 billion, up 6.5% year over year. Management also raised its outlook, forecasting 2026 adjusted EBITDA of $5.05 billion to $5.20 billion.
• Insiders have been selling shares amid ongoing risks: Insiders sold 106,484 shares worth approximately $28.9 million over the past 90 days, while payer pressure, uninsured patients, surgery headwinds and transition-related benefits could affect recurring performance.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty-one ratings firms that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $280.16.

Several research firms have commented on THC. UBS Group upped their price target on Tenet Healthcare from $288.00 to $308.00 and gave the company a "buy" rating in a report on Monday, July 27th. Royal Bank Of Canada upped their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an "outperform" rating in a research note on Monday, July 27th. Stephens reissued an "overweight" rating and issued a $285.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. Wells Fargo & Company upped their price objective on Tenet Healthcare from $231.00 to $281.00 and gave the company an "overweight" rating in a research note on Monday, August 3rd. Finally, Raymond James Financial restated an "outperform" rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th.

Insider Activity

In other news, Director J. Robert Kerrey sold 12,010 shares of the firm's stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the transaction, the director directly owned 4,794 shares in the company, valued at $1,264,273.68. This trade represents a 71.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Lisa Foo sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares of the company's stock, valued at $2,144,674.96. This represents a 74.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 106,484 shares of company stock worth $28,898,063. Company insiders own 0.97% of the company's stock.

Institutional Trading of Tenet Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. V Square Quantitative Management LLC bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth $26,000. Mather Group LLC. grew its position in Tenet Healthcare by 126.9% during the third quarter. Mather Group LLC. now owns 118 shares of the company's stock valued at $30,000 after buying an additional 66 shares during the period. Trust Co. of Vermont purchased a new stake in Tenet Healthcare during the second quarter worth about $37,000. MADDEN SECURITIES Corp purchased a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $38,000. Finally, Compass Financial Management LLC purchased a new stake in Tenet Healthcare in the second quarter worth $57,000. Institutional investors own 95.44% of the company's stock.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported third-quarter earnings of $6.64 per share, well above the $4.68 consensus estimate, while revenue rose 6.5% year over year to $6.28 billion versus expectations of $5.49 billion. Strong hospital performance and cost discipline drove the earnings beat. Tenet Healthcare surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Management raised its 2026 financial outlook and forecast adjusted EBITDA of $5.05 billion to $5.20 billion. Conifer transition-related items are expected to contribute to results, while improving hospital margins and higher-acuity services are strengthening the business outlook. Tenet forecasts 2026 adjusted EBITDA
• Positive Sentiment: Deutsche Bank raised its price target to $320 from $260 and maintained a Buy rating, signaling increased confidence in Tenet’s earnings momentum and valuation potential. Deutsche Bank raises Tenet price target
• Neutral Sentiment: Guggenheim modestly reduced its price target to $306 from $307 but retained a Buy rating, leaving its fundamental view constructive. Guggenheim Tenet Healthcare rating
• Negative Sentiment: Investors continue to face risks from payer pressure, uninsured patients and surgery-related headwinds. Commentary also noted that the headline earnings beat included transition-related benefits, which could make the results less representative of recurring performance. Tenet high-acuity strategy and third-quarter performance

Tenet Healthcare Trading Up 1.0%

Tenet Healthcare stock opened at $273.25 on Friday. The stock has a market cap of $22.00 billion, a P/E ratio of 7.92, a P/E/G ratio of 1.03 and a beta of 1.20. The company has a quick ratio of 1.35, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. Tenet Healthcare has a 12 month low of $157.58 and a 12 month high of $283.05. The company's fifty day simple moving average is $264.85 and its 200-day simple moving average is $220.34.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The business had revenue of $6.28 billion during the quarter, compared to analysts' expectations of $5.49 billion. During the same quarter in the previous year, the business posted $3.70 EPS. The firm's quarterly revenue was up 6.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Tenet Healthcare will post 20.90 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. NYSE: THC is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.